Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abiomed Inc (ABMD)

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,135,514
  • Shares Outstanding, K 45,564
  • Annual Sales, $ 1,032 M
  • Annual Income, $ 136,510 K
  • 60-Month Beta 1.34
  • Price/Sales 11.52
  • Price/Cash Flow 51.28
  • Price/Book 7.90
Trade ABMD with:

Options Overview Details

View History
  • Implied Volatility 51.85% ( +0.05%)
  • Historical Volatility 66.48%
  • IV Percentile 89%
  • IV Rank 66.18%
  • IV High 63.64% on 05/24/22
  • IV Low 28.78% on 08/06/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 160
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 5,131
  • Open Int (30-Day) 4,406

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 1.04
  • Number of Estimates 6
  • High Estimate 1.15
  • Low Estimate 0.98
  • Prior Year 1.10
  • Growth Rate Est. (year over year) -5.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
226.46 +17.61%
on 05/20/22
298.50 -10.77%
on 05/05/22
-10.81 (-3.90%)
since 04/27/22
3-Month
226.46 +17.61%
on 05/20/22
342.38 -22.21%
on 03/31/22
-45.96 (-14.72%)
since 02/25/22
52-Week
226.46 +17.61%
on 05/20/22
379.30 -29.78%
on 11/10/21
-19.51 (-6.83%)
since 05/27/21

Most Recent Stories

More News
SCAI 2022 Scientific Sessions Highlight Impella Research, Advancements to Improve Cardiogenic Shock Outcomes

Abiomed (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, will feature the most recent Impella research and technological advances aimed at improving outcomes for acute...

ABMD : 266.34 (+2.06%)
Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

OMCL : 112.99 (+2.98%)
ABMD : 266.34 (+2.06%)
PDCO : 31.87 (+1.34%)
AMN : 95.63 (+2.01%)
Why Abiomed (ABMD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

ABMD : 266.34 (+2.06%)
Integra (IART) Q1 Earnings Top Estimates, Margins Expand

Integra's (IART) updated 2022 financial guidance calls for strong year-over-year organic growth.

UNH : 507.11 (+0.97%)
IART : 62.15 (+1.29%)
ABMD : 266.34 (+2.06%)
TFX : 290.09 (+1.62%)
QIAGEN (QGEN) Q1 Earnings Surpass Estimates, 2022 View Up

QIAGEN (QGEN) exited first-quarter 2022 with better-than-expected results on strength in the non-COVID product portfolio driving the top line.

UNH : 507.11 (+0.97%)
ABMD : 266.34 (+2.06%)
QGEN : 47.39 (+3.86%)
TFX : 290.09 (+1.62%)
Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates

Abiomed's (ABMD) strength in Impella product revenues drives its Q4 top line.

UNH : 507.11 (+0.97%)
ABMD : 266.34 (+2.06%)
QGEN : 47.39 (+3.86%)
CNC : 84.41 (+3.08%)
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year

ABIOMED, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced financial results for the quarter and fiscal year ended March 31, 2022.

ABMD : 266.34 (+2.06%)
Integra LifeSciences (IART) Tops Q1 Earnings and Revenue Estimates

Integra (IART) delivered earnings and revenue surprises of 8.82% and 3.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

IART : 62.15 (+1.29%)
ABMD : 266.34 (+2.06%)
MedTech Stocks' Apr 28 Earnings Roster: ABMD, SYK & More

The MedTech companies' Q1 results are likely to reflect solid rebound in base business sales. Let's see how ABMD, SYK, BAX and DXCM are poised ahead of their earnings releases.

BAX : 76.16 (+0.54%)
SYK : 236.50 (+0.66%)
DXCM : 289.08 (+3.01%)
ABMD : 266.34 (+2.06%)
World’s First Patient Implanted with Impella BTR Minimally Invasive Heart Pump

Abiomed (Nasdaq: ABMD) announces the first patient in the world has been successfully implanted with Impella Bridge-to-Recovery (BTR) as part of the heart pump’s U.S. Food and Drug Administration (FDA)...

ABMD : 266.34 (+2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abiomed Inc. is engaged in developing, manufacturing and marketing of medical products, designed to assist or replace the pumping function of the failing heart.

See More

Key Turning Points

3rd Resistance Point 277.57
2nd Resistance Point 273.20
1st Resistance Point 269.77
Last Price 266.34
1st Support Level 261.98
2nd Support Level 257.61
3rd Support Level 254.18

See More

52-Week High 379.30
Fibonacci 61.8% 320.91
Fibonacci 50% 302.88
Fibonacci 38.2% 284.84
Last Price 266.34
52-Week Low 226.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar